Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.
LL-37 Frequently Asked Questions
LL-37 is a human antimicrobial peptide with multiple therapeutic applications: wound healing acceleration (30–60% faster), immune enhancement, biofilm disruption, skin rejuvenation, and infection control. It operates through multiple mechanisms including direct antimicrobial action, immune modulation, angiogenesis, and collagen synthesis. Works best as adjunctive therapy in combination with standard medical care.
What is LL-37?
LL-37 (human cathelicidin) is an endogenous antimicrobial peptide—a 37-amino acid protein produced by neutrophils, macrophages, and epithelial cells. It's the only human member of the cathelicidin family and has multiple biological roles: antimicrobial defense, immune modulation, tissue repair, and inflammation resolution. Research compound, not FDA-approved for therapeutic use.
Is LL-37 legal to buy?
LL-37 is legal to purchase in most countries as a research peptide. It's not FDA-approved for medical use, so sales are restricted to "research purposes only." Always verify local laws, sourcing from reputable vendors, and medical supervision before use.
Where can I buy LL-37?
Reputable peptide vendors include Ascension Peptides, Particle Peptides, Limitless Life Nootropics, and Integrative Peptides. Always verify vendor legitimacy, quality certifications (HPLC purity testing), and ensure proper licensing. Avoid suspiciously cheap sources—quality LL-37 costs $80–200 per vial.
How do I prepare LL-37 for injection?
LL-37 powder is reconstituted with bacteriostatic water or saline: Add water slowly to powder vial (target 1–2 mg/mL). Let dissolve gently at room temperature or 4°C for 5–10 minutes. Gently roll to mix—do not shake (causes aggregation). Store at 2–8°C, use within 7–14 days. Always use sterile technique.
What are the side effects of LL-37?
Mild side effects: transient localized redness/swelling at injection site, mild systemic inflammatory markers for 24–48 hours. Rare side effects: hemolysis at extremely high systemic doses (above 100 mcg/kg), immune overstimulation in autoimmune conditions. Dose-dependent cytotoxicity above 75 mcg/mL in vitro. Most users tolerate well at standard doses (50–100 mcg).
How long does LL-37 last in the body?
LL-37 has a short half-life due to rapid proteolytic degradation: systemic LL-37 persistence is measured in minutes to hours (estimated 15–30 minutes). Local LL-37 (wound, injection site) lasts longer, with therapeutic effects persisting days to weeks. This short half-life is the main limitation for systemic use but supports local/topical applications.
Can I take LL-37 orally?
Oral LL-37 has minimal bioavailability because it's destroyed by gastric and intestinal proteases. Not effective for systemic effects. Rectal/colonic application or encapsulation in protease-resistant formulations may have better absorption—research ongoing. Injectable or topical routes strongly preferred.
Does LL-37 interact with medications?
LL-37 has low risk of drug interactions since it's a peptide (not absorbed systemically at oral doses) and acts through immune mechanisms rather than metabolic pathways. However, use caution with immunosuppressive medications—they may reduce LL-37 efficacy. Consult healthcare provider if combining with prescription drugs.
How long before I see results from LL-37?
Timeline varies by application: Immune markers shift within 24–72 hours. Wound improvement visible within 1–2 weeks. Skin changes appear after 4–8 weeks. Full benefits often manifest over 4–12 weeks. Consistent application and appropriate dosing crucial for timely results.
Can I combine LL-37 with other peptides?
Yes. Common stacks: LL-37 + BPC-157 (wound healing), LL-37 + TB-500 (tissue repair), LL-37 + Ipamorelin (immune + growth hormone effects). Reduce individual doses when stacking. Offset cycles (rotate peptides) can provide continuous coverage. Always research peptide compatibility.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →Frequently Asked Questions
Conclusion
LL-37 is a promising research peptide with solid clinical potential for wound healing, immunity, and infection control. Beginners should start with conservative protocols, prioritize quality and sterile technique, and combine with professional medical guidance. Consistency and patience over 4–12 weeks typically yield noticeable results.